A long-standing belief about HIV has quietly shaped how scientists think about the virus. For decades, researchers described ...

People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked.

A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated.

Merck is carving out its own place in the evolving HIV treatment space with an FDA approval for its Idvynso, a combination ...

More than four decades into the HIV epidemic, progress has transformed treatment and prevention, yet the need remains urgent.

Four years ago, a team of research physicians at Weill Cornell Medicine began treatment for an HIV patient, in the hopes of finding a cure. This February marked 14 months since the patient was free of ...

From bloodstream infections to tuberculosis and HIV, Associate Professor Sophia Archuleta has spent nearly two decades ...

A missing nutrient in breast milk might explain health problems among children of moms with HIV Their breast milk has significantly lower levels of tryptophan, an essential amino acid Tryptophan is ...

The Ghana AIDS Commission (GAC) has said despite progress made in the HIV fight in the country, the disease still remains a ...

The Mozambican health authorities on Wednesday launched a long-acting injectable PrEP against HIV, which is capable of reducing the risk of infections by more than 99 per cent.A PrEP is a pre-exposure ...